Breaking News

Definiens, Clarient Expand Imaging Analysis Pact

By Kristin Brooks | February 3, 2014

To offer validated applications for clinical pathology

Definiens, a provider of image analysis for digital pathology and diagnostics, has entered an agreement with Clarient Diagnostic Services, expanding the use of Definiens’ automated image analysis software and solutions in Clarient's validated clinical applications for immunohistochemistry testing in breast cancer. Definiens' Cognition Network Technology automatically classifies and quantitates key tissue features as part of Clarient's Scope IA Platform offering.
 
"At Clarient, we combine world class pathology with innovation and our goal is to make a difference to physicians and their patients," said Kenneth Bloom, MD, chief medical officer, Clarient Diagnostic Services. "Our work with Definiens will enable us to offer high quality, robust readouts with fast turnaround time. This means physicians will have better patient insights for diagnosis."
 
"We are really pleased to work with Clarient on creating these validated applications for their routine clinical work. Running thousands of patient slides through our algorithms and seeing the computer-aided diagnosis in action is really gratifying," said Thomas Heydler, chief executive officer of Definiens.  
 

blog comments powered by Disqus
  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • CMOs: A Flexibility Alternative

    CMOs: A Flexibility Alternative

    Philip K. Burns, CRO-Consulting||January 28, 2016
    A look at how to include CMOs as an option to improve overall flexibility

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.